PERRONE CONGEDI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 271
EU - Europa 67
AS - Asia 27
AF - Africa 1
Totale 366
Nazione #
US - Stati Uniti d'America 266
IT - Italia 26
SE - Svezia 18
CN - Cina 12
IN - India 12
DE - Germania 7
FI - Finlandia 6
CA - Canada 5
SG - Singapore 3
FR - Francia 2
IE - Irlanda 2
RO - Romania 2
UA - Ucraina 2
DK - Danimarca 1
NL - Olanda 1
TG - Togo 1
Totale 366
Città #
Fairfield 48
Ashburn 27
Chandler 25
Houston 17
Cambridge 16
Woodbridge 13
San Paolo di Civitate 12
Seattle 12
Wilmington 12
Ann Arbor 7
Beijing 6
Lawrence 6
Millbury 6
Princeton 6
Plano 5
Grafing 4
Ottawa 4
Dearborn 3
Fremont 3
Norwalk 3
Andover 2
Bremen 2
Dallas 2
Dublin 2
Phoenix 2
San Diego 2
Bangalore 1
Boston 1
Guangzhou 1
Hefei 1
Helsinki 1
Jacksonville 1
Jinhua 1
Kunming 1
Leawood 1
Lomé 1
Los Angeles 1
Nanchang 1
Nice 1
Redwood City 1
Shenyang 1
Toronto 1
Totale 263
Nome #
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 113
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 79
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 56
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 47
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study 46
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 41
Totale 382
Categoria #
all - tutte 902
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 9 20 15
2019/202091 12 4 1 6 8 10 14 11 10 6 1 8
2020/202143 6 10 1 1 1 3 0 3 9 5 1 3
2021/202266 0 1 8 2 7 3 0 8 4 1 20 12
2022/202383 13 31 6 5 8 7 2 3 7 0 1 0
2023/202427 3 5 3 5 2 4 0 1 2 2 0 0
Totale 382